1. Home
  2. QTRX

QTRX

Quanterix Corporation

Logo Quanterix Corporation

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

Founded: N/A Country:
United States
United States
Employees: N/A City: BILLERICA
Market Cap: 826.4M IPO Year: 2017
Target Price: $32.67 AVG Volume (30 days): 342.6K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.86 EPS Growth: N/A
52 Week Low/High: $11.39 - $29.70 Next Earning Date: 05-07-2024
Revenue: $122,368,000 Revenue Growth: 15.96%
Revenue Growth (this year): 18.14% Revenue Growth (next year): 17.84%

Share on Social Networks: